Eastgate Biotech (ETBI) Stock Price, News & Analysis

Company Overview

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. Eastgate Biotech Corp. has collaboration with Biotech Corp. to develop a vaccine against COVID-19. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada.

Key Stats

• Today's Range: $0.0030 to $0.0030
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0045
• Volume: N/A
• Average Volume: 42,048 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ETBI Stock Analysis - Frequently Asked Questions

How have ETBI shares performed this year?

Eastgate Biotech's stock was trading at $0.0045 at the start of the year. Since then, ETBI stock has decreased by 33.3% and is now trading at $0.0030.

How do I buy shares of Eastgate Biotech?

Shares of ETBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Eastgate Biotech own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Eastgate Biotech investors own include Delcath Systems (DCTHD), OPKO Health (OPK), Ovintiv (OVV), Cassava Sciences (SAVA), Avino Silver & Gold Mines (ASM), CVS Health (CVS) and Myovant Sciences (MYOV).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:ETBI
• Previous Symbol: OTCMKTS:ESAQ
• CIK: 1099574
• Web: www.eastgatebiotech.com
• Phone: 647-692-0652
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A